Journal of Diagnostics Concepts & Practice ›› 2019, Vol. 18 ›› Issue (04): 377-382.doi: 10.16150/j.1671-2870.2019.04.001
• Experts forum • Next Articles
Received:2019-07-09
Online:2019-08-25
Published:2019-08-25
CLC Number:
| [1] |
Suenaga Y, Kanda M, Ito S, et al. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer[J]. World J Gastrointest Oncol, 2019, 11(1):17-27.
doi: 10.4251/wjgo.v11.i1.17 URL |
| [2] | Jia J, Zhang P, Gou M, et al. The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer[J]. Dis Markers, 2019, 2019:6812045. |
| [3] | Ashworth T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death[J]. Aust Med J, 1869, 14:146. |
| [4] |
Arigami T, Uenosono Y, Yanagita S, et al. Clinical significance of circulating tumor cells in blood from patients with gastric cancer[J]. Ann Gastroenterol Surg, 2017, 1(1):60-68.
doi: 10.1002/ags3.12005 URL |
| [5] |
Liu JL, Gao W, Kang QM, et al. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis[J]. PLoS One, 2013, 8(8):e71930.
doi: 10.1371/journal.pone.0071930 URL |
| [6] |
Yie SM, Lou B, Ye SR, et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse[J]. Ann Surg Oncol, 2008, 15(11):3073-3082.
doi: 10.1245/s10434-008-0069-x URL |
| [7] |
Bertazza L, Mocellin S, Marchet A, et al. Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival[J]. J Transl Med, 2009, 7:111.
doi: 10.1186/1479-5876-7-111 pmid: 20028510 |
| [8] |
Arigami T, Uenosono Y, Hirata M, et al. Expression of B7-H4 in blood of patients with gastric cancer predicts tumor progression and prognosis[J]. J Surg Oncol, 2010, 102(7):748-752.
doi: 10.1002/jso.21722 URL |
| [9] |
Huang MY, Tsai HL, Huang JJ, et al. Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer[J]. Transl Oncol, 2016, 9(4):340-347.
doi: 10.1016/j.tranon.2016.06.006 URL |
| [10] |
Yamamoto S, Shimizu K, Fei J, et al. Ex vivo culture of circulating tumor cells using magnetic force-based coculture on a fibroblast feeder layer[J]. Biotechnol J, 2016, 11(11):1433-1442.
doi: 10.1002/biot.201600084 pmid: 27731546 |
| [11] |
Emami SS, Nekouian R, Akbari A, et al. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer[J]. J Cancer Res Ther, 2019, 15(1):115-119.
doi: 10.4103/jcrt.JCRT_1020_16 URL |
| [12] |
Necula L, Matei L, Dragu D, et al. Recent advances in gastric cancer early diagnosis[J]. World J Gastroenterol, 2019, 25(17):2029-2044.
doi: 10.3748/wjg.v25.i17.2029 URL |
| [13] |
Roh MS, Lee HW, Jung SB, et al. Expression of miR-200c and its clinicopathological significance in patients with colorectal cancer[J]. Pathol Res Pract, 2018, 214(3):350-355.
doi: 10.1016/j.prp.2018.01.005 URL |
| [14] |
Wu Y, Song Y, Xiong Y, et al. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer[J]. Cell Physiol Biochem, 2017, 43(3):945-958.
doi: 10.1159/000481648 URL |
| [15] |
Fukushima Y, Iinuma H, Tsukamoto M, et al. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer[J]. Oncol Rep, 2015, 33(2):573-582.
doi: 10.3892/or.2014.3614 URL |
| [16] |
Hollis M, Nair K, Vyas A, et al. MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity[J]. World J Gastroenterol, 2015, 21(27):8284-8292.
doi: 10.3748/wjg.v21.i27.8284 URL |
| [17] |
Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules exis-ting as highly base-paired rod-like structures[J]. Proc Natl Acad Sci U S A, 1976, 73(11):3852-3856.
doi: 10.1073/pnas.73.11.3852 pmid: 1069269 |
| [18] |
Li P, Chen S, Chen H, et al. Using circular RNA as a novel type of biomarker in the screening of gastric cancer[J]. Clin Chim Acta, 2015, 444:132-136.
doi: 10.1016/j.cca.2015.02.018 URL |
| [19] |
Sun H, Tang W, Rong D, et al. Hsa_circ_0000520, a potential new circular RNA biomarker, is involved in gastric carcinoma[J]. Cancer Biomark, 2018 Feb 6; 21(2):299-306.
doi: 10.3233/CBM-170379 URL |
| [20] | Shi P, Wan J, Song H, et al. The emerging role of circular RNAs in gastric cancer[J]. Am J Cancer Res, 2018, 8(10):1919-1932. |
| [21] |
Lei B, Tian Z, Fan W, et al. Circular RNA: a novel biomarker and therapeutic target for human cancers[J]. Int J Med Sci, 2019, 16(2):292-301.
doi: 10.7150/ijms.28047 pmid: 30745810 |
| [22] |
Weng W, Wei Q, Toden S, et al. Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer[J]. Clin Cancer Res, 2017, 23(14):3918-3928.
doi: 10.1158/1078-0432.CCR-16-2541 URL |
| [23] |
Shahjehan F, Kamatham S, Kasi PM. Role of Circulating Tumor DNA in Gastrointestinal Cancers: Update From Abstracts and Sessions at ASCO 2018[J]. Front Oncol, 2019, 9:358.
doi: 10.3389/fonc.2019.00358 pmid: 31139561 |
| [24] |
Fang WL, Lan YT, Huang KH, et al. Clinical significance of circulating plasma DNA in gastric cancer[J]. Int J Cancer, 2016, 138(12):2974-2983.
doi: 10.1002/ijc.30018 URL |
| [25] |
Hu Y, Guo H, Chen Y, et al. The mutational landscape of circulating cell free DNA in patients with colorectal adenoma and carcinoma[J]. J Clin Oncol, 2018, 36(15_suppl):e15662.
doi: 10.1200/JCO.2018.36.15_suppl.e15662 URL |
| [26] |
Kim K, Shin DG, Park MK, et al. Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection[J]. Ann Surg Treat Res, 2014, 86(3):136-142.
doi: 10.4174/astr.2014.86.3.136 URL |
| [27] |
Kehagias P, Vandeputte C, Ameye L, et al. High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib[J]. J Clin Oncol, 2018, 36 (15_suppl):3532.
doi: 10.1200/JCO.2018.36.15_suppl.3532 URL |
| [28] |
Murray DH, Symonds EL, Young GP, et al. Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival[J]. J Cancer Res Clin Oncol, 2018, 144(9):1741-1750.
doi: 10.1007/s00432-018-2701-x pmid: 29992492 |
| [29] |
Sánchez-Zauco N, Torres J, Gómez A, et al. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study[J]. BMC Cancer, 2017, 17(1):384.
doi: 10.1186/s12885-017-3310-9 pmid: 28558708 |
| [30] |
Vainer N, Dehlendorff C, Johansen JS. Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer[J]. Oncotarget, 2018, 9(51):29820-29841.
doi: 10.18632/oncotarget.25661 pmid: 30038723 |
| [31] |
Hong JT, Son DJ, Lee CK, et al. Interleukin 32, inflammation and cancer[J]. Pharmacol Ther, 2017, 174:127-137.
doi: 10.1016/j.pharmthera.2017.02.025 URL |
| [32] |
Liu Y, Yao J. Research progress of cystatin SN in cancer[J]. Onco Targets Ther, 2019, 12:3411-3419.
doi: 10.2147/OTT.S194332 URL |
| [1] | . [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 551-554. |
| [2] | ZHOU Sifeng, XU Haishu, FAN Xinsheng. Application of metabolomics of different biological samples in study of OSAHS biomarkers [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 535-540. |
| [3] | XIONG Xinhai, LI Jia, DING Xiaosong, JI Congcong, SHI Hourong, XIANG Minjie. Leishmaniasis with secondary hemophagocytic syndrome: a case report [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 524-526. |
| [4] | BAO Zhiyao, MENG Wenkai, SHEN Jimin, LI Qingyun. Hematogenous disseminated pneumonia secondary to suppurative tonsillitis in adults: a case report and literature review [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 520-523. |
| [5] | LI Lei, YUAN Fei, WANG Chaofu, XU Haimin, WANG Ting. Ampullary adenocarcinoma: analysis of the clinicopathological features and prognostic factors [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 355-361. |
| [6] | GUO Yebing, ZHENG Jinfeng. The extra-gastrointestinal stromal tumors located in vagina: A case report and literature review [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(03): 405-407. |
| [7] | . [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(01): 102-104. |
| [8] | HUANG Pei, REN Rujing, PAN Yu, LIN Guozhen, WANG Gang. Early-onset Alzheimer′s disease complicated with cerebral amyloid angiopathy: A case report [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(01): 86-89. |
| [9] | . [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(01): 99-101. |
| [10] | . [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 529-532. |
| [11] | . [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 582-583. |
| [12] | . [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 584-587. |
| [13] | . [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 588-591. |
| [14] | . [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 596-598. |
| [15] | . [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(05): 512-514. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
